Intech Investment Management LLC Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Intech Investment Management LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 169,283 shares of the company’s stock after selling 33,880 shares during the quarter. HCA Healthcare accounts for approximately 0.8% of Intech Investment Management LLC’s holdings, making the stock its 15th biggest holding. Intech Investment Management LLC owned approximately 0.07% of HCA Healthcare worth $68,802,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Bangor Savings Bank raised its position in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth about $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock valued at $5,608,990 over the last 90 days. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Barclays dropped their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Leerink Partners upped their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. UBS Group increased their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Trading Down 0.6 %

NYSE HCA opened at $333.00 on Thursday. The company has a fifty day simple moving average of $381.99 and a two-hundred day simple moving average of $358.12. The stock has a market cap of $84.35 billion, a P/E ratio of 14.95, a P/E/G ratio of 1.29 and a beta of 1.68. HCA Healthcare, Inc. has a 12-month low of $245.84 and a 12-month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.79%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.